WHO Director-General s opening remarks at the Member State Information Session on COVID-19 - 22 April
Format
Honourable Ministers, Excellencies, dear colleagues and friends,
Good morning, good afternoon and good evening to all Member States, and thank you for joining us once again.
This Saturday marks the one-year anniversary of the launching of the Access to COVID-19 Tools Accelerator.
Tomorrow we will hold a special press conference involving the principals of all the partners in the ACT Accelerator.
As you know, the ACT Accelerator was conceived with two major objectives: rapid development of vaccines, diagnostics and therapeutics; and equitable access to those tools.
10 things we learned from Dave Grohl s BBC Reel Stories interview — Kerrang!
kerrang.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kerrang.com Daily Mail and Mail on Sunday newspapers.
COVID-19 Solidarity Response Fund, ACT Accelerator face cash crunch
downtoearth.org.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from downtoearth.org.in Daily Mail and Mail on Sunday newspapers.
WHO’s COVID-19 Solidarity Response Fund appeals for continued support
One year ago WHO created the COVID-19 Solidarity Response Fund to respond to the unprecedented show of support by individuals and companies to help WHO in the fight against COVID-19.
Powered by the UN Foundation and the Swiss Philanthropy Foundation, it was developed as an innovative platform to enable private companies, individuals and other organizations to contribute directly to WHO s efforts to prevent, detect, and respond to COVID-19 around the world.
The fund s first year has seen unprecedented solidarity: to date, more than 661 000 donors have contributed nearly US$ 250 million. The funds have be used to provide millions of frontline workers with critical personal protective equipment, medical supplies, and testing kits; to manage misinformation and the infodemic; support vulnerable populations like refugees and displaced persons; and helped accelerate the research on vaccines, tests, and treatments.